Fesoterodine is indicated in adults for treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur with overactive bladder syndrome.
For this indication, competent medicine agencies globally authorize below treatments:
For: Adults (18-64) Elders (65+)
Oral, between 4 and 8 milligrams, once daily.
The recommended starting dose is 4 mg once daily. Based upon individual response, the dose may be increased to 8 mg once daily. The maximum daily dose is 8 mg.
Full treatment effect was observed between 2 and 8 weeks. Hence, it is recommended to reevaluate the efficacy for the individual patient after 8 weeks of treatment.
Fesoterodine tablets are to be taken once daily with liquid and swallowed whole. Fesoterodine can be administered with or without food.